Form 4 Tracker
Roger Jeffs

Director; Director, Chief Executive Officer · 14 filings · Latest: Jun 10, 2026

Axsome Therapeutics, Inc.
Liquidia Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LQDA
SERENDIPITY BIOPHARMA LLCMay 8, 2026
Proposed Sale
$42.28100,000$4.2M
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 7, 2026
Sale
$42.0925,000$1.1M1,348,095
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 6, 2026
Sale
$40.7825,000$1.0M1,373,095
LQDA
Roger JeffsDirector, Chief Executive OfficerMay 5, 2026
Sale
$40.1025,000$1.0M1,398,095
LQDA
SERENDIPITY BIOPHARMA LLCMay 7, 2026
Proposed Sale
$42.1425,000$1.1M
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 17, 2026
Sale
$40.6018,839$765.0K1,423,095
LQDA
SERENDIPITY BIOPHARMA LLCApr 17, 2026
Proposed Sale
$41.4068,839$2.8M
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 16, 2026
Sale
$40.3125,000$1.0M1,441,934
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 15, 2026
Sale
$40.1425,000$1.0M1,466,934
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 14, 2026
Sale
$40.003,300$132.0K1,491,934
LQDA
SERENDIPITY BIOPHARMA LLCApr 16, 2026
Proposed Sale
$40.1225,000$1.0M
LQDA
SERENDIPITY BIOPHARMA LLCApr 15, 2026
Proposed Sale
$38.7124,733$957.4K
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 10, 2026
Sale
$40.1221,433$859.9K1,495,234
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 13, 2026
Sale
$38.3732,744$1.3M1,137,599
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 10, 2026
Option Exercise
28,1671,170,343
LQDA
Roger JeffsDirector, Chief Executive OfficerApr 9, 2026
Sale
$40.1225,000$1.0M1,516,667
LQDA
SERENDIPITY BIOPHARMA LLCApr 10, 2026
Proposed Sale
$40.3225,000$1.0M
LQDA
SERENDIPITY BIOPHARMA LLCApr 9, 2026
Proposed Sale
$38.1925,000$954.8K
AXSM
JEFFS ROGERSep 2, 2025
Proposed Sale
$123.6813,464$1.7M
AXSM
JEFFS ROGERAug 29, 2025
Proposed Sale
$121.2720,000$2.4M